Scientists dive into kidney tissue to uncover diabetes drug secrets

NCT ID NCT07444203

First seen Mar 02, 2026 · Last updated May 13, 2026 · Updated 9 times

Summary

This study looks at kidney tissue from adults with diabetic kidney disease who are already having a kidney biopsy or surgery. Researchers want to understand how SGLT2 inhibitors, a common diabetes medicine, change the kidney's molecular makeup. Participants donate a tissue slide, blood, and urine samples, and their health is tracked over time. The goal is to learn why these drugs help protect the kidneys.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Penn Presbyterian Medical Center

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.